Article Details

AstraZeneca to Buy Alexion for $39 Billion to Add Rare-Disease Treatments

Retrieved on: 2020-12-12 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to Buy Alexion for $39 Billion to Add Rare-Disease Treatments. View article details on hiswai:

Excerpt

As stock markets have soared and debt financing remains cheap because of <b>central bank</b> policies, companies have resumed their quest for growth ...

Article found on: www.nytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo